Federal Court Validates Dow AgroSciences Position In Key Herbicide Tolerance Technology Case

Dow AgroSciences LLC, a subsidiary of The Dow Chemical Company (NYSE: DOW), has prevailed in its motion for summary judgment in a key patent infringement lawsuit involving its highly-anticipated Enlist™ Weed Control System. The lawsuit, filed in December 2010 by Bayer CropScience SA, alleged that Dow AgroSciences’ herbicide tolerance technology infringed one of its patents. In a ruling issued on September 27, 2012, a federal district court sided with Dow AgroSciences, determining that its Enlist technology does not infringe Bayer’s patent, and that Bayer’s overbroad interpretation of its patent claims would render them invalid.

Dow AgroSciences has repeatedly expressed its confidence in its legal position in this case, and the Court’s decision has confirmed the company’s conviction and resolve to advance technology for its customers.

“We are pleased that the ruling fully supports Dow AgroSciences’ position. The court correctly found that Dow AgroSciences did not infringe Bayer’s intellectual property,” said William Wales, Vice President and General Counsel, Dow AgroSciences. “Dow AgroSciences remains committed to ensuring our innovative Enlist technology is available for farmers as they struggle with weed control issues.”

About Dow AgroSciences

Dow AgroSciences, based in Indianapolis, Indiana, USA, develops leading-edge crop protection and plant biotechnology solutions to meet the challenges of the growing world. Dow AgroSciences is a wholly owned subsidiary of The Dow Chemical Company and had annual global sales of $5.7 billion in 2011. Learn more at www.dowagro.com. Follow Dow AgroSciences on Facebook and YouTube or subscribe to our News Release RSS Feed.

Enlist is a trademark of Dow AgroSciences LLC. Components of the Enlist Weed Control System have not yet received regulatory approvals; approvals are pending. The information presented is not an offer for sale. ©2012 Dow AgroSciences LLC

Copyright Business Wire 2010

If you liked this article you might like

Why Bayer's $66 Billion Takeover of Monsanto Probably Won't Happen Until 2018

Cramer: The Market Is Back to the Late '80s, Early '90s

DowDupont Closes Higher in First Day of Trading, Company Still Faces Challenges

FMC Stock's Impressive Rally Has Another 20% to Gain: Jim Cramer

Jim Cramer on Why FMC Was Upgraded by Bank of America